ZA200803856B - Leucine rich composition - Google Patents
Leucine rich compositionInfo
- Publication number
- ZA200803856B ZA200803856B ZA200803856A ZA200803856A ZA200803856B ZA 200803856 B ZA200803856 B ZA 200803856B ZA 200803856 A ZA200803856 A ZA 200803856A ZA 200803856 A ZA200803856 A ZA 200803856A ZA 200803856 B ZA200803856 B ZA 200803856B
- Authority
- ZA
- South Africa
- Prior art keywords
- leucine rich
- rich composition
- composition
- leucine
- rich
- Prior art date
Links
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 title 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/18—Erythrocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Obesity (AREA)
- Marine Sciences & Fisheries (AREA)
- Cardiology (AREA)
- Polymers & Plastics (AREA)
- Rheumatology (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Communicable Diseases (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05077339 | 2005-10-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200803856B true ZA200803856B (en) | 2009-04-29 |
Family
ID=36228553
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200803856A ZA200803856B (en) | 2005-10-12 | 2008-05-06 | Leucine rich composition |
Country Status (12)
Country | Link |
---|---|
US (1) | US20080275120A1 (xx) |
EP (2) | EP1774973A1 (xx) |
JP (2) | JP2009511576A (xx) |
CN (1) | CN101325951A (xx) |
AU (1) | AU2006300046A1 (xx) |
BR (1) | BRPI0617358A2 (xx) |
CA (1) | CA2625819A1 (xx) |
IL (1) | IL190671A0 (xx) |
MX (1) | MX2008004734A (xx) |
RU (1) | RU2428977C2 (xx) |
WO (1) | WO2007043870A1 (xx) |
ZA (1) | ZA200803856B (xx) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1774973A1 (en) * | 2005-10-12 | 2007-04-18 | Nutricia N.V. | Leucine rich composition |
WO2009157759A1 (en) | 2008-06-23 | 2009-12-30 | N.V. Nutricia | Nutritional composition for improving the mammalian immune system |
WO2010002242A1 (en) | 2008-07-02 | 2010-01-07 | N.V. Nutricia | Nutritional composition for improving muscle function and daily activity |
ITMI20081405A1 (it) * | 2008-07-29 | 2010-01-30 | Velleja Res Srl | Formulazioni orali istantanee, gelificanti a temperatura ambiente, utili per contrastare il deperimento organico e la sindrome depressiva connessi a cachessia, anoressia, malattia metabolica, malattia endocrina e disfagia |
WO2011078654A1 (en) * | 2009-12-24 | 2011-06-30 | N.V. Nutricia | Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis |
WO2011119023A1 (en) * | 2010-03-26 | 2011-09-29 | N.V. Nutricia | Low protein infant formula with increased essential amino acids |
ES2667011T3 (es) | 2010-07-05 | 2018-05-09 | Beth Israel Deaconess Medical Center, Inc. | Monoacilgliceroles sn-2 y malabsorción lipídica |
WO2012005568A1 (en) | 2010-07-07 | 2012-01-12 | N.V. Nutricia | Nutritional composition for the stimulation of muscle protein synthesis |
EP2705844B1 (en) * | 2011-04-13 | 2019-05-22 | Ajinomoto Co., Inc. | Nutritional composition |
US20140037604A1 (en) * | 2011-04-18 | 2014-02-06 | Nestec S.A. | Nutritional compositions comprising alpha-hydroxyisocaproic acid |
MX2015012821A (es) * | 2013-03-14 | 2016-05-31 | Abbott Lab | Tratamiento de resistencia a la insulina asociado con la inactividad fisica prolongada. |
CN112931879A (zh) | 2013-06-10 | 2021-06-11 | N·V·努特里奇亚 | 超重或肥胖成年人在体重减轻项目期间的肌肉保持 |
FR3015860B1 (fr) * | 2013-12-30 | 2019-08-16 | Pronokal Health Group, Sociedad Limitada | Composition alimentaire de regime pour diminuer l'inflammation de bas grade a court et long terme comprenant de l'acide docosahexaenoique |
CN105769844B (zh) * | 2016-05-25 | 2019-01-11 | 天津嘉氏堂医美科技有限公司 | 一种含精氨酸的组合物及制剂 |
WO2018047980A1 (ja) * | 2016-09-09 | 2018-03-15 | 味の素株式会社 | 認知症またはうつ状態の予防または改善用組成物 |
JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
CN111295187A (zh) | 2017-08-14 | 2020-06-16 | 胺细拉健康公司 | 用于治疗肝脏疾病的氨基酸组合物 |
EP3810123A1 (en) | 2018-06-20 | 2021-04-28 | Axcella Health Inc. | Compositions and methods for the treatment of fat infiltration in muscle |
CN113519850A (zh) * | 2020-04-13 | 2021-10-22 | 内蒙古蒙牛乳业(集团)股份有限公司 | 肿瘤全营养乳剂、其制备方法和用途 |
CN114159422B (zh) * | 2021-09-29 | 2023-02-28 | 北京天赋神奇科技有限公司 | 一种含镁水溶性欧米伽3脂肪酸在促进小肠吸收能力中的应用 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4780475A (en) * | 1986-02-03 | 1988-10-25 | Cerra Frank B | Preparation for the prevention of catabolism |
US20010041187A1 (en) * | 1998-10-20 | 2001-11-15 | Carl W Hastings | Performance-enhancing dietary supplement |
US6890571B2 (en) * | 2002-05-14 | 2005-05-10 | National Starch And Chemical Investment Holding Corporation | Slowly digestible starch product |
JP2005529980A (ja) * | 2002-06-19 | 2005-10-06 | ネムローゼ・フェンノートシャップ・ニュートリシア | 代謝ストレスを受けている哺乳動物における異化を治療または予防し、同化を促進する方法及び組成物 |
US20040087490A1 (en) * | 2002-09-20 | 2004-05-06 | Troup John P. | Nutritional compositions |
US7037522B2 (en) * | 2002-09-27 | 2006-05-02 | Western Holdings, L.L.C. | Nocturnal muscle enhancing composition and method |
US7288570B2 (en) * | 2002-12-20 | 2007-10-30 | Nutricia N.V. | Stimulation of in vivo production of proteins |
US8697679B2 (en) * | 2003-03-07 | 2014-04-15 | N.V. Nutricia | Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
CN1835762B (zh) * | 2003-06-30 | 2010-05-12 | 雀巢技术公司 | 用于治疗和/或预防与2型糖尿病有关的功能障碍和抗胰岛素性的组合物 |
NZ552706A (en) * | 2004-07-19 | 2011-01-28 | Nutricia Nv | Use of aspartate for regulating glucose levels in blood |
EP1774973A1 (en) * | 2005-10-12 | 2007-04-18 | Nutricia N.V. | Leucine rich composition |
-
2005
- 2005-11-11 EP EP20050077579 patent/EP1774973A1/en not_active Withdrawn
-
2006
- 2006-10-11 EP EP06799504A patent/EP1945199A1/en not_active Withdrawn
- 2006-10-11 JP JP2008535476A patent/JP2009511576A/ja active Pending
- 2006-10-11 WO PCT/NL2006/000515 patent/WO2007043870A1/en active Application Filing
- 2006-10-11 BR BRPI0617358-6A patent/BRPI0617358A2/pt not_active IP Right Cessation
- 2006-10-11 RU RU2008118341/15A patent/RU2428977C2/ru not_active IP Right Cessation
- 2006-10-11 AU AU2006300046A patent/AU2006300046A1/en not_active Abandoned
- 2006-10-11 CA CA002625819A patent/CA2625819A1/en not_active Abandoned
- 2006-10-11 CN CNA2006800466429A patent/CN101325951A/zh active Pending
- 2006-10-11 MX MX2008004734A patent/MX2008004734A/es active IP Right Grant
-
2008
- 2008-04-07 IL IL190671A patent/IL190671A0/en unknown
- 2008-04-10 US US12/100,590 patent/US20080275120A1/en not_active Abandoned
- 2008-05-06 ZA ZA200803856A patent/ZA200803856B/xx unknown
-
2013
- 2013-03-21 JP JP2013058860A patent/JP2013139470A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2006300046A1 (en) | 2007-04-19 |
RU2428977C2 (ru) | 2011-09-20 |
JP2009511576A (ja) | 2009-03-19 |
EP1945199A1 (en) | 2008-07-23 |
JP2013139470A (ja) | 2013-07-18 |
US20080275120A1 (en) | 2008-11-06 |
WO2007043870A1 (en) | 2007-04-19 |
BRPI0617358A2 (pt) | 2011-07-26 |
CA2625819A1 (en) | 2007-04-19 |
CN101325951A (zh) | 2008-12-17 |
IL190671A0 (en) | 2008-11-03 |
MX2008004734A (es) | 2008-10-23 |
RU2008118341A (ru) | 2009-11-20 |
EP1774973A1 (en) | 2007-04-18 |
AU2006300046A2 (en) | 2008-05-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL190671A0 (en) | Leucine rich composition | |
IL229521A0 (en) | A new preparation | |
IL185906A0 (en) | Composition | |
IL184421A0 (en) | Fertilizer-compatible composition | |
EP1930012A4 (en) | COMPOSITION CONTAINING A CELLO-OLIGOSACCHARIDE | |
GB0522658D0 (en) | Composition | |
EP1865042A4 (en) | ANTI-FREEZE COMPOSITION | |
ZA200705932B (en) | Fertilizer-compatible composition | |
GB0519164D0 (en) | Composition | |
GB0508250D0 (en) | Composition | |
GB0506044D0 (en) | Composition | |
EP1847249A4 (en) | hair dye | |
GB0507167D0 (en) | Composition | |
EP1947129A4 (en) | PHOTORADIC AND PHOTOCYSTIC CURING COMPOSITION | |
EP1864573A4 (en) | AGRICULTURAL CHEMICAL COMPOSITION | |
ZA200707917B (en) | Composition | |
GB0505760D0 (en) | Novel composition | |
GB0502341D0 (en) | Composition | |
GB0513641D0 (en) | Anti-egeing composition | |
GB0513367D0 (en) | Novel composition | |
HK1101657A2 (en) | Novel composition | |
GB0510286D0 (en) | Composition | |
GB0517912D0 (en) | Composition | |
GB0503182D0 (en) | Composition | |
GB0523760D0 (en) | Composition |